| | ccRCC cases, n (%) |
|---|
| Variables | Early stagea | Late stagea |
|---|
| Age, mean (SD) | 58.46 (9.85) | 59.57 (8.45) |
| BMI, mean (SD) | 30.70 (6.39) | 30.12 (7.07) |
| Sex |
| Male | 67 (74.44) | 68 (73.91) |
| Female | 23 (25.56) | 24 (26.09) |
| Age |
| < =60 | 44 (48.89) | 43 (46.74) |
| > 60 | 46 (51.11) | 49 (53.26) |
| Smoking status |
| Never | 40 (44.44) | 43 (46.74) |
| Former | 43 (47.78) | 42 (45.65) |
| Current | 7 (7.78) | 7 (7.61) |
| BMI |
| < 30 | 45 (50.00) | 57 (61.96) |
| >= 30 | 45 (50.00) | 35 (38.04) |
| Hypertension |
| Yes | 65 (72.22) | 68 (73.91) |
| No | 25 (27.78) | 24 (26.09) |
| Diabetes |
| Yes | 19 (21.11) | 17 (18.48) |
| No | 71 (78.89) | 75 (81.52) |
| Tumor gradeb |
| 1 | 1 | 0 (0.00) |
| 2 | 43 (47.78) | 9 (9.78) |
| 3 | 37 (41.11) | 52 (56.52) |
| 4 | 8 (8.89) | 29 (31.52) |
| None | 1 (1.11) | 2 (2.17) |
| Recurrence |
| Yes | 17 (18.9) | 74 (80.4) |
| No | 73 (81.1) | 18 (19.6) |
| Death |
| Yes | 11 (33.3) | 22 (66.7) |
| No | 79 (53.0) | 70 (47.0) |
| Treatment |
| Surgery-only | 64 (70.33) | 76 (83.52) |
| Surgery-plus-chemotherapy | 27 (29.67) | 15 (16.48) |
- aEarly stage indicated stage I or II disease; late stage indicated stage III disease. The staging criteria derived from NCCN guidelines 2019 v.2.0
- bTumor grade based on Fuhrman criteria
